Hearing:
“The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part III: Transparency and Accountability”
Committee on Oversight and Accountability
Tuesday, July 23, 2024 (10:00 AM)
2154 RHOB
Washington, D.C.
Witnesses
Dr. Patrick Conway, MD, MSc
CEO, Optum Rx
Added
07/18/2024 at 01:47 PM
- Statement
[PDF]
Added
07/22/2024 at 06:45 PM
- Truth in Testimony
[PDF]
Added
07/23/2024 at 08:55 AM
- Bio
[PDF]
Added
07/22/2024 at 06:45 PM
Mr. David Joyner
President; CVS Caremark, Executive Vice President; CVS Health
Added
07/18/2024 at 01:47 PM
- Statement
[PDF]
Added
07/22/2024 at 06:45 PM
- Truth in Testimony
[PDF]
Added
07/22/2024 at 06:45 PM
- Bio
[PDF]
Added
07/22/2024 at 06:45 PM
Dr. Adam Kautzner, PharmD
President, Express Scripts and Evernorth Care Management
Added
07/18/2024 at 01:47 PM
- Statement
[PDF]
Added
07/22/2024 at 06:45 PM
- Truth in Testimony
[PDF]
Added
07/22/2024 at 06:45 PM
- Bio
[PDF]
Added
07/22/2024 at 06:45 PM
Support Documents
- Notice
[PDF]
- Memo
[PDF]
Added
07/18/2024 at 01:47 PM
Hearing Record
- Attendance Sheet
[PDF]
Added
07/23/2024 at 10:09 PM
First Published:
July 16, 2024 at 04:38 PM
Last Updated:
July 23, 2024 at 10:09 PM